API SYNTHESIS INTERNATIONAL: Tarvicopan

DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, this will not stop me, Only God and death can..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai), INDIA, worlddrugtracker, 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.8 Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributionn, सुकून उतना ही देना प्रभू, जितने से जिंदगी चल जाये।औकात बस इतनी देना,कि औरों का भला हो जाये।...........P.S. : The views expressed are my personal and in no-way suggest the views of the professional body or the company that I represent.

Wednesday, 14 October 2026

Tarvicopan

Tarvicopan

CAS2378381-06-5

MW C24H22N2O4 MW 402.4 g/mol

2-[2-[[7-[2-(aminomethyl)-4-pyridinyl]-2-methyl-1-benzofuran-5-yl]methoxy]phenyl]acetic acid

[2-({7-[2-(aminomethyl)pyridin-4-yl]-2-methyl-1-benzofuran-5-yl}methoxy)phenyl]acetic acid
complement factor D inhibitor, MWL2DF9UJJ

Tarvicopan is an investigational small-molecule compound that acts as an inhibitor of complement factor D.

Mechanism and Clinical Context

Complement Factor D Inhibitor: It specifically targets factor D, a rate-limiting enzyme in the alternative pathway of the complement system. The complement system is a crucial part of the innate immune response, but its overactivation is linked to several autoimmune and inflammatory diseases.

PAT

US11370774,

Compound 112c

PAT

WO2019195720

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2019195720&_cid=P11-MV8WTL-54517-1

Scheme-112